StudyThe lancet. Healthy longevitySep 2027
Seeley AE, van der Veen R, Wang A, Glogowska M, Hayward G, Williamson E, Sheppard JP.
Background In older patients (≥65 years), the evidence for continued statin prescription is scarce. Although statins are commonly discontinued in the context of advancing age or frailty, there is little evidence to guide decision making. Hence, we aimed to inv...
PreprintPreprintNov 2026
Murugadoss K, Venkatakrishnan A, Soundararajan V.
Semaglutide lowers cardiovascular events in adults with obesity, but whether it slows biological aging of the heart, and whether any such effect is explained by weight loss, is unknown. We developed and validated a hybrid convolutional and transformer deep lea...
StudyGeroScienceNov 2026
Ditchfield C, Macleod M, Price JMJ, Davis ET, Jones SW.
GLP-1 and GIP/GLP-1 receptor agonists produce substantial weight loss in clinical trials but significant loss of lean body mass is reported. Whether this reflects a direct pharmacological effect on skeletal muscle or an indirect consequence of caloric restrict...
StudyGeroScienceOct 2026
Smith C, Garza K, Azari H, Vellers H, Abdelrahman M, Dhanasekara CS, Salmon AB, Liang H, Fernandez E, Musi N, Massett MP, Albracht-Schulte K.
Aerobic exercise attenuates age-related physiological decline, potentially through favorable modulation of gut microbiota diversity. The purpose of this study was to characterize aerobic exercise training (ET)-induced alterations in the gut microbiome of aging...
StudyJournal of exercise rehabilitationOct 2026
Park JW, Yoo DH, Jo SG, Jee YS.
This pilot randomized controlled trial (RCT) aimed to determine whether an 8-week progressive step exercise program improves sarcopenic outcomes compared with treadmill exercise and a nonexercise control condition in women with sarcopenia. The primary outcomes...
StudyFrontiers in cardiovascular medicineOct 2026
Seri A, Yue B, Khawaja M, Tang WHW, Birnbaum Y, Lavie CJ, Virani SS, Strauss M, Krittanawong C.
Cardiovascular health is a key factor in human longevity, affecting not just lifespan but also the quality of aging. We synthesize evidence across four risk factor domains: genetic and epigenetic factors (APOE, FOXO3, telomere biology, epigenetic clocks); meta...